Alpha risk, also called the risk of a Type I error, is the chance of wrongly rejecting the null hypothesis when it is actually true. In other words, it happens when research suggests a result is significant, but in reality, there is no real effect.
In statistical research, the null hypothesis (H0) assumes there is no effect, no difference, or no relationship. Rejecting this hypothesis incorrectly creates a false positive result. Managing alpha risk is essential to protect the integrity of research findings.
In medical research, a Type I error could mean concluding that a new treatment works when it does not. In manufacturing, it could mean wrongly identifying a machine as faulty. In both cases, decisions based on false positives can be costly and harmful.
Researchers often adjust the alpha level:
Alpha risk is a cornerstone of statistical testing. Choosing and communicating the correct significance level helps others judge the reliability of results. Lowering alpha reduces the risk of false positives but may require larger samples to detect real effects. Managing alpha risk carefully supports valid conclusions and trustworthy science.